Squalene Market Size, Share, Growth, Industry Analysis, Trends and Dynamics, By Types (Animal-based, Phytosqualen, Synthetic biotechnology), By Applications (Cosmetics, Food supplements, Healthcare & Pharmaceuticals, Others), Regional Insights and Forecast to 2035
- Last Updated: 21-October-2026
- Base Year: 2025
- Historical Data: 2021 - 2024
- Region: Global
- Format: PDF
- Report ID: GGI103946
- SKU ID: 30499578
- Pages: 101
Download FREE Sample
Squalene Market Size
The Global Squalene Market size was USD 186.5 Million in 2025 and is projected to touch USD 201.81 Million in 2026 and USD 218.5 Million in 2027 to USD 411.32 Million by 2035, exhibiting a CAGR of 8.23% during the forecast period [2026-2035].
Squalene is moving from a niche lipid ingredient to a strategically important raw material across skincare, nutrition, and biopharmaceutical formulation. Buyers are increasingly separating suppliers by origin, purity, and sustainability credentials, with about 48% of formulators now asking for traceable, non-animal sourcing. Meanwhile, roughly 35% of new ingredient qualifications involve stability and oxidation performance, pushing producers toward refined, high-purity grades.
![]()
In the US Squalene Market, demand is shaped by a strong premium skincare culture and active vaccine and drug delivery research. Nearly 41% of regional consumption is linked to cosmetic and personal care formulations, while about 24% is tied to pharmaceutical and nutraceutical uses, encouraging steady imports of plant-derived and fermentation-based grades.
Key Findings
- Market Size: Starting at $201.81M in 2026, projected to touch $218.5M in 2027 to $411.32M by 2035 at a CAGR of 8.23%.
- Growth Drivers: Clean beauty reformulation influences 46% of new launches, while 32% of supplement brands add lipid-based ingredients for skin and cardiovascular positioning.
- Trends: Plant-derived and fermentation-based grades feature in 44% of new ingredient listings, while 29% of buyers demand certified sustainable sourcing.
- Key Players: Sophim, Amyris, Kishimoto Special Liver Oil, Maruha Nichiro Corporation, Vestan & more.
- Regional Insights: Europe leads with 34% share, followed by Asia-Pacific at 30%, North America at 27%, and Middle East & Africa at 9%, reflecting cosmetic strength and growing wellness demand.
- Challenges: Marine supply variability affects 31% of animal-derived output, and cost gaps limit about 26% of small formulators from switching grades.
- Industry Impact: Squalene appears in nearly 38% of premium moisturizer formulations, and vaccine adjuvant research accounts for about 12% of specialty demand.
- Recent Developments: Fermentation capacity additions represent about 40% of recent supplier announcements, with 22% focused on pharmaceutical-grade purification upgrades.
The Squalene Market stands out because the same molecule is supplied through very different value chains. Marine-derived output is tied to fishing patterns, olive-derived material follows agricultural cycles, and fermentation depends on feedstock and process efficiency. About 36% of supply contracts now include origin-specific clauses, signaling that provenance has become a commercial variable rather than a footnote.
Another distinctive feature is the split between volume and value. Cosmetics consume the largest share of tonnage, yet pharmaceutical-grade material commands a disproportionately higher price per unit because purity and documentation standards are stricter. Roughly 14% of volume sold into regulated applications generates a far larger share of supplier margins than its weight suggests.
![]()
Squalene Market Trends
Sourcing is the defining theme. As animal welfare and marine conservation concerns grow, about 44% of new ingredient listings now rely on plant-derived or biotechnology-based material, and nearly 39% of large cosmetic brands have formal policies restricting shark-derived inputs. Suppliers are responding with certified olive, amaranth, and sugarcane-fermented offerings, and many are publishing sustainability documentation to shorten customer qualification cycles.
Application breadth is the second major shift. Beyond moisturizers, squalane, the hydrogenated and more stable form, appears in roughly 33% of newly launched serums, sunscreens, and hair care products because of its light texture and oxidative stability. Nutraceutical positioning is also gaining ground, with about 21% of new lipid-focused supplements referencing skin barrier or metabolic wellness claims. In pharmaceuticals, emulsion-based adjuvant and drug delivery research keeps pulling interest toward ultra-high-purity grades, rewarding producers with stronger quality systems and consistent batch performance.
Squalene Market Dynamics
Growth in fermentation-based and pharmaceutical-grade supply
Biotechnology routes give producers a way to deliver consistent, animal-free squalene at scale, and customers are noticing. About 37% of cosmetic and supplement brands say they would shift volume to fermentation-derived material if pricing gaps narrow, while nearly 25% of pharmaceutical developers are evaluating non-marine supply for adjuvant and delivery systems. Regional diversification adds another opening, since roughly 28% of new personal care launches in emerging markets position squalane as a premium naturals ingredient, creating room for suppliers that can pair documentation with dependable lead times and flexible pack sizes.
Rising demand for clean and skin-compatible ingredients
Consumers are scrutinizing ingredient lists, and squalene and squalane fit the preference for lightweight, skin-identical lipids. Around 46% of new skincare launches highlight clean or naturally derived claims, while about 32% of dietary supplement brands add lipid-based ingredients for skin and cardiovascular positioning. Aging populations and higher dermatology awareness also contribute, with roughly 27% of premium anti-aging products featuring squalane for barrier support, keeping formulation demand consistent across both mass and prestige channels.
| Market Driver | Impact Rank | Contribution | 2026-2028 | 2029-2031 | 2032-2035 |
|---|---|---|---|---|---|
| Clean and natural beauty reformulation | High | 3.7% | High | High | Medium |
| Shift toward plant and fermentation-based sourcing | High | 3.1% | Medium | High | High |
| Growth of nutraceutical and wellness supplements | Medium | 2.1% | Medium | Medium | Medium |
| Pharmaceutical adjuvant and drug delivery research | Medium | 1.5% | Medium | High | High |
| Premium anti-aging and sun care demand | Low | 0.9% | Medium | Medium | Low |
| Others | Lowest | 0.4% | Low | Low | Low |
| Total Driver Contribution | 11.7% |
RESTRAINTS
"Raw material variability and price gaps"
Supply stability remains the sector's most persistent weakness. Marine-derived output depends on fishing volumes and regulation, and about 31% of animal-based supply is exposed to seasonal or policy-driven swings. Olive-derived material tracks harvest outcomes, so a weak crop can tighten availability for several months. Cost is the other barrier, since fermentation-based and refined plant grades can carry noticeably higher prices, and roughly 26% of small and mid-sized formulators say this gap limits their willingness to switch. Purity and documentation requirements for regulated uses add further expense, slowing qualification for newer suppliers.
| Market Restraint | Impact Rank | Negative CAGR Impact | 2026-2028 | 2029-2031 | 2032-2035 |
|---|---|---|---|---|---|
| Raw material supply variability | High | -1.5% | High | Medium | Medium |
| Price premium of biotechnology and plant-based grades | Medium | -1.1% | High | Medium | Low |
| Stringent purity and regulatory qualification requirements | Low | -0.7% | Medium | Medium | Medium |
| Others | Lowest | -0.3% | Low | Low | Low |
| Total Restraint Impact | -3.6% |
CHALLENGES
"Sustainability scrutiny and scale-up complexity"
Producers face growing pressure to prove that their sourcing is responsible. About 39% of large cosmetic brands now apply formal restrictions on shark-derived inputs, which forces marine-based suppliers to defend or rework their positioning. Scaling alternatives is not simple either, because fermentation yields, downstream purification, and feedstock costs all affect competitiveness, and nearly 23% of new capacity projects report delays tied to process optimization. Meanwhile, inconsistent grade definitions between squalene and squalane complicate buyer comparisons, leaving roughly 20% of purchasing teams reliant on extra testing before approving a new supplier.
Segmentation Analysis
The Squalene Market is segmented by source and by end use, and each axis reveals a distinct commercial logic. Origin determines cost, perception, and regulatory comfort, with plant-derived and biotechnology-based sources together accounting for about 60% of volume. Application mix shows where demand concentrates, as cosmetics alone represent close to 52% of consumption, while healthcare and supplement uses supply the more specification-intensive pockets of demand.
By Type
Animal-based
Animal-based squalene, historically sourced from deep-sea shark liver oil, still holds about 40% of the market thanks to established supply chains and attractive pricing. However, its share has been eroding as roughly 39% of major brands restrict marine-derived inputs. Demand persists in price-sensitive supplements and industrial uses, though regulatory and reputational pressures continue to limit long-term expansion.
Phytosqualen
Plant-derived squalene, mostly extracted from olive oil by-products, amaranth, and other botanical sources, accounts for roughly 38% of the market. About 45% of new clean beauty launches prefer this origin because it offers a natural, cruelty-free story. Supply depends on agricultural cycles, which can create price fluctuations, but strong brand pull keeps this segment growing steadily.
Synthetic biotechnology
Synthetic biotechnology, based on engineered fermentation of sugars into squalene, represents about 22% of the market and is the fastest-expanding source. Roughly 37% of formulators view it as the most scalable animal-free option, and about 25% of pharmaceutical developers are testing it for regulated applications. Consistency and traceability are its main selling points, though cost competitiveness still shapes uptake.
By Application
Cosmetics
Cosmetics lead with about 52% of demand, with squalene and squalane used in moisturizers, serums, sun care, and hair products. Roughly 33% of newly launched facial care items include squalane for its light feel and oxidative stability. Premium and clean beauty positioning keeps formulators loyal to the ingredient, even as they compare origins more carefully than before.
Food supplements
Food supplements account for about 19% of consumption, supported by interest in skin health, cardiovascular wellness, and antioxidant positioning. Around 30% of lipid-focused supplement launches reference squalene, usually in softgel formats. Brands are shifting toward plant-derived material, with nearly 35% of new products declaring non-marine origin to reassure health-conscious and ethically minded buyers.
Healthcare & Pharmaceuticals
Healthcare and pharmaceutical uses hold about 21% of demand, covering adjuvant systems, topical therapies, and drug delivery emulsions. Although volumes are modest, strict documentation and purity requirements mean about 14% of total tonnage generates a much larger portion of supplier margins. Roughly 25% of developers evaluating new supply now prioritize non-marine sources to reduce dependency risk.
Others
Other uses, including industrial lubricants, veterinary products, and specialty chemicals, make up about 8% of demand. Around 28% of demand in this group comes from niche technical formulations where stability and emollient properties matter. The segment is small and fragmented, but it provides useful volume diversification for suppliers during cosmetic demand slowdowns.
![]()
Squalene Market Regional Outlook
Regional performance mirrors the geography of cosmetic manufacturing, marine resources, and wellness spending. Europe holds about 34% of the global market, Asia-Pacific follows with 30%, North America contributes 27%, and Middle East & Africa accounts for 9%, totaling 100%. Mature regions focus on sustainable sourcing and premium formulation, while emerging regions are expanding through personal care adoption and supplement consumption.
North America
North America represents about 27% of the market, supported by a deep premium skincare industry and active pharmaceutical research. Around 41% of regional consumption is tied to cosmetics and personal care, while nearly 24% serves nutraceutical and pharmaceutical uses. Demand for plant-derived and fermentation-based grades is rising, with about 43% of new regional launches emphasizing animal-free sourcing and ingredient transparency.
Europe
Europe leads with about 34% of the market, anchored by established cosmetic manufacturers, strong ingredient regulation, and early adoption of sustainable sourcing. Roughly 49% of regional product launches highlight natural or responsibly sourced claims, and about 31% of ingredient suppliers operate local production or refining capacity. High regulatory expectations favor producers able to supply documented, traceable material.
Asia-Pacific
Asia-Pacific holds about 30% of the market and is the most dynamic region, supported by expanding beauty and personal care consumption and a long tradition of marine-derived oils in Japan. Nearly 38% of regional demand comes from cosmetics, while about 26% relates to supplements. Growing middle-class spending and local manufacturing capacity are encouraging both domestic production and import of premium grades.
Middle East & Africa
Middle East & Africa accounts for about 9% of the market, with demand centered on personal care imports and a developing wellness sector. Around 46% of regional consumption flows through premium cosmetic and fragrance-adjacent categories, while about 18% is linked to healthcare and supplement uses. Rising urban incomes and retail expansion are gradually widening ingredient awareness and supplier presence.
List of Key Squalene Market Companies Profiled
- Sophim
- Amyris
- Kishimoto Special Liver Oil
- Maruha Nichiro Corporation
- Vestan
- Arbee
- Nucelis LLC
- Empresa Figueirense de Pesca
Top Companies with Highest Market Share
- Sophim: Holds about 17% of the global market, supported by strong positioning in plant-derived squalane for cosmetics.
- Amyris: Commands about 13% share, driven by fermentation-based production and animal-free ingredient credentials.
Investment Analysis and Opportunities
Investment is gravitating toward supply security and origin diversification. About 42% of ingredient-sector capital activity is directed at fermentation and plant extraction capacity, since buyers want alternatives to volatile marine sourcing. Roughly 27% of spending targets purification and quality systems that support pharmaceutical-grade qualification, an area where documentation depth creates durable pricing power. Strategic partnerships are also rising, with about 30% of cosmetic brands entering multi-year supply agreements to secure traceable material. Emerging markets present further openings, as nearly 29% of new personal care manufacturing projects there include squalane in premium product lines, encouraging suppliers to build regional distribution and technical support.
New Products Development
Innovation centers on purity, sustainability, and functional performance. About 41% of recent product introductions highlight non-animal origin with documented traceability, while nearly 34% focus on improved oxidative stability and odor profile for sensitive formulations. Hydrogenated squalane grades with lighter texture appear in around 36% of new cosmetic ingredient lines, and about 22% of launches target nutraceutical softgel and emulsion applications. Pharmaceutical-oriented development is also advancing, with roughly 18% of new grades designed to meet tighter endotoxin and impurity expectations. Suppliers are increasingly bundling technical dossiers and sustainability data with product launches to accelerate customer approval.
Recent Developments
- March 2024– Sophim expanded plant-derived squalane capacity: Sophim increased production of olive-derived squalane to meet cosmetic demand, targeting about 20% higher output. The move supports brands where roughly 45% of new launches prefer plant-based origin, and strengthens supply reliability for premium skincare formulators.
- July 2024– Amyris refined fermentation-based squalane offering: Amyris advanced its sugarcane-fermented squalane portfolio with improved consistency and traceability documentation. About 37% of formulators view fermentation as the most scalable animal-free route, and the update aims to reduce qualification time for new customers by nearly 15%.
- October 2024– Kishimoto Special Liver Oil upgraded purification processes: Kishimoto invested in refining improvements to raise purity and reduce impurity levels by about 12%. The upgrade helps the company defend its position in supplement and specialty uses, where roughly 40% of animal-derived demand still relies on established marine supply.
- February 2025– Vestan strengthened sustainable sourcing programs: Vestan introduced enhanced sourcing verification for its squalene supply, responding to the 39% of major brands applying origin restrictions. The initiative increases transparency across the chain and helps secure repeat contracts with cosmetic and personal care buyers.
- June 2025– Nucelis LLC advanced biotechnology-derived squalene development: Nucelis progressed its engineered fermentation pathway, targeting yield improvements of about 18% to improve cost competitiveness. About 25% of pharmaceutical developers are evaluating non-marine supply, and the effort positions the company for regulated, high-purity applications.
Report Coverage
This report examines the Squalene Market through a structured framework covering market dynamics, segmentation, regional performance, competitive positioning, and innovation direction. It evaluates demand by source, including animal-based at about 40%, phytosqualen at about 38%, and synthetic biotechnology at about 22%, and by application across cosmetics, food supplements, healthcare and pharmaceuticals, and other uses, with cosmetics representing close to 52% of consumption. Regional coverage spans Europe at 34%, Asia-Pacific at 30%, North America at 27%, and Middle East & Africa at 9% of global share. The competitive assessment profiles leading suppliers, noting that the top two companies jointly hold about 30% of the market. The study also reviews drivers, restraints, opportunities, and challenges, quantifying their relative influence on adoption patterns, and tracks themes such as non-animal sourcing, which features in over 40% of recent product introductions. Investment trends, product development priorities, and notable manufacturer activity are included to support strategic planning, supplier benchmarking, and informed sourcing decisions across the ingredient value chain.
Squalene market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 201.81 Million in 2026 |
|
|
Market Size Value By |
USD 411.32 Million by 2035 |
|
|
Growth Rate |
CAGR of 8.23% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Download FREE Sample
Frequently Asked Questions
-
What value is the Squalene market expected to touch by 2035?
The global Squalene market is expected to reach USD 411.32 Million by 2035.
-
What CAGR is the Squalene market expected to exhibit by 2035?
The Squalene market is expected to exhibit a CAGR of 8.23% by 2035.
-
Who are the top players in the Squalene market?
Sophim, Amyris, Kishimoto Special Liver Oil, Maruha Nichiro Corporation, Vestan, Arbee, Nucelis LLC, Empresa Figueirense de Pesca
-
What was the value of the Squalene market in 2025?
In 2025, the Squalene market value stood at USD 186.5 Million.
About the Author(s):
This report was authored by the Chemicals & Materials Research Team at Global Growth Insights. The team specializes in specialty chemicals, advanced materials, polymers, coatings, composites, petrochemicals, and industrial raw materials. Their expertise includes market sizing, competitive analysis, supply and demand assessment, and long-term industry forecasting.
Our Clients
Download FREE Sample